Supplemental Figure 2 from An Oral Formulation of YK-4-279: Preclinical Efficacy and Acquired Resistance Patterns in Ewing Sarcoma

Autor:	Joseph A. Ludwig, James E. O'Dorisio, Kirk S. Culotta, Dannette K. Doolittle, Adrianna S. Buford, Rebecca L. Maywald, Ramani A. Aiyer, Vandhana Ramamoorthy, Brian A. Menegaz, Salah-Eddine Lamhamedi-Cherradi
Rok vydání:	2023
Popis:	Supplemental Figure 2. Nuclear, cytoplasmic and total RHA levels are identical between sensitive and YK-Resistant ES cell lines.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8bff659f99b7d0c4ee14a7794ff944 https://doi.org/10.1158/1535-7163.22501953 Zobrazit plný text záznamu